Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol

Patients on anticoagulant therapy for the prevention of cardiovascular accidents present an increased risk of bleeding following dental and oral surgery. Four recently introduced non-vitamin K antagonist oral anticoagulants, namely dabigatran etexilate (direct thrombin inhibitor), rivaroxaban, apixa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupi, Saturnino Marco, Baena, Arianna Rodriguez y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551164/
https://www.ncbi.nlm.nih.gov/pubmed/32825272
http://dx.doi.org/10.3390/healthcare8030281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551164/
https://www.ncbi.nlm.nih.gov/pubmed/32825272
http://dx.doi.org/10.3390/healthcare8030281

Ejemplares similares